Oxidative status and plasma lipid profile in β-thalassemia patients

Hemoglobin

Volumn 39, Issue 1, 2015, Pages 36-41

  Boudrahem Addour, Nassima ^a   Izem Meziane, Malika ^a   Bouguerra, Khadidja ^a   Nadjem, Nassima ^a   Zidani, Nadia ^b   Belhani, Meriem ^b   Djerdjouri, Bahia ^a  

^a UNIVERSITY OF SCIENCES AND TECHNOLOGY HOUARI BOUMEDIENE   (Algeria)

^b Department of Hematology Isaad Hassani Hospital   (Algeria)

Author keywords

Lipid oxidative stress; Thalassemia intermedia ( TI); thalassemia major ( TM)

Indexed keywords

CATALASE; DEFERIPRONE; DEFEROXAMINE; FERRITIN; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; TRIACYLGLYCEROL; GLUTATHIONE; LIPID;

ADULT; ARTICLE; BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CHELATION THERAPY; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; FERRITIN BLOOD LEVEL; HEMOLYSIS; HUMAN; HYPERTRIGLYCERIDEMIA; HYPOCHOLESTEROLEMIA; INTESTINE ABSORPTION; IRON OVERLOAD; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL; SPLENECTOMY; TRIACYLGLYCEROL BLOOD LEVEL; ADOLESCENT; BLOOD; COMPLICATION; LIPID METABOLISM; METABOLISM; OXIDATION REDUCTION REACTION; YOUNG ADULT;

ADOLESCENT; ADULT; BETA-THALASSEMIA; CATALASE; FEMALE; GLUTATHIONE; HUMANS; LIPID METABOLISM; LIPIDS; MALE; MALONDIALDEHYDE; OXIDATION-REDUCTION; OXIDATIVE STRESS; YOUNG ADULT;

EID: 84921898917     PISSN: 03630269     EISSN: 1532432X     Source Type: Journal    
DOI: 10.3109/03630269.2014.979997     Document Type: Article

References (28)

1. Fibach E, Rachmilewitz EA. The role of oxidative stress in hemolytic anemia. Curr Mol Med. 2008;8(7):609-619.
2. Valko M, Morris H, Cronin MT. Metals, toxicity and oxidative stress. Curr Med Chem. 2005;12(10):1161-1208.
3. Maioli M, Vigna GB, Tonolo GB, et al. Plasma lipoprotein composition apolipoprotein (a) concentration and isoforms in β-thalassemia. Atherosclerosis. 1997;131(1):127-133.
4. Ricchi P, Ammirabile M, Spasiano A, et al. Hypocholesterolemia in adult patients with thalassemia: A link with the severity of genotype in thalassemia intermedia patients. Eur J Haematol. 2009;89(3):219-222.
5. Papasnastasiou DA, Siorokou T, Haliotis FA. β Thalassemia and factors affecting the metabolism of lipids and lipoproteins. Haematologica (Budapest). 1996;27(3):143-153.
6. Livrea MA, Tesoriere L, Maggio D, et al. Oxidative modification of low-density lipoprotein and atherogenetic risk in β-thalassemia. Blood. 1998;92(10):3936-3942.
7. Hartman C, Tamary H, Tamir A, Shabad E. Hypocholesterolemia in children and adolescents with β-thalassemia intermedia. J Pediatr. 2002;141(4):543-547.
8. Nasr MR, Abdelmaksoud AM, Abdel-Aal KS, et al. Plasma lipid profile and lipid peroxidation in β-thalassemic children. J Clin Lipidol. 2008;2(6):405-409.
9. Kassab-Chekir A, Laradi S, Ferchichi S, et al. Oxidant, antioxidant status and metabolic data in patients with β thalassemia. Clin Chim Acta. 2003;338(1-2):79-86.
10. Shazia Q, Mohammad ZH, Rahman T, Shekhar HU. Correlation of oxidative stress with serum trace element levels and antioxidant enzyme status in β thalassemia majors patients: A review of the literature. Anemia. 2012;2012:270923. doi: 10.1155/2012/270923.
11. Goldfarb AW, Rachmilewitz EA, Eiseinberg S. Abnormal low and high density lipoproteins in homozygous β thalassaemia. Br J Haematol. 1991;79(3):481-486.
12. Madani H, Rahimi Z, Manavi Shad M, et al. Plasma lipids and lipoproteins in children and young adults with major β thalassemia from western Iran: Influence of genotype. Mol Biol Rep. 2011;38(4):2573-2578.
13. Colah R, Nadkarni A, Gorakshakar A, et al. Impact of β globin gene mutations on the clinical phenotype of β thalassemia in India. Blood Mol Cells Dis. 2004;33(2):153-157.
14. Naithani R, Chandra J, Bhattacharjee J, et al. Peroxidative Stress and antioxidant enzymes in children with β-thalassemia major. Pediatr Blood Cancer. 2006;46(7):780-785.
15. Beers RF, Sizer IW. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J Biol Chem. 1952;195(1):133-140.
16. Boyne AF, Ellman GL. A methodology for analysis of tissue sulfhydryl components. Anal Biochem. 1972;46(2):639-653.
17. Ohkawa H, Ohishi W, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979;95(2):351-358.
18. Brewer JR. New features of the National Cholesterol Education Program Adult Treatment Panel III Lipid Lowering Guidelines. Clin Cardiol. 2003;26(4 Suppl 3):19-24.
19. Haghpanah S, Davani M, Samadi B, et al. Serum lipid profiles in patients with β thalassemia major and intermedia in southern Iran. J Res Med Sci. 2010;15(3):150-154.
20. Shalev H, Kapelushnik J, Moser A, et al. Hypocholesterolemia in chronic anemias with increased erythropoeitic activity. Am J Hematol. 2007;82(3):199-202.
21. Bordbar M, Haghpanah S, Afrasiabi A, et al. Genotype-phenotype correlation related to lipid profile in β-thalassemia major and intermedia in southern Iran. J Clin Lipidol. 2012;6(2):108-113.
22. Das N, Das Chowdhury T, Chattopadhyay A, Datta AG. Attenuation of oxidative stress induced changes in thalassemic erythrocytes by vitamin E. Pol J Pharmacol. 2004;56(1):85-96.
23. Wassmann S, Wassmann K, Nickenig G. Modulation of oxidant and antioxidant enzyme expression and function in vascular cells. Hypertension. 2004;44(4):381-386.
24. Scott MD, van Den Berg JJ, Repka T, et al. Effect of excess α-hemoglobin chains on cellular and membrane oxidation in model β-thalassemic erythrocytes. J Clin Invest. 1993;91(4):1706-1712.
25. Cighetti G, Duca L, Bortone L, et al. Oxidative status and malondialdehyde in β thalassaemia patients. Eur J Clin Inves. 2002;32(Suppl 1):55-60.
26. Abdalla MY, Fawzi M, Al Maloul SR, et al. Increased oxidative stress and iron overload in Jordanian β-thalassemic children. Hemoglobin. 2011;35(1):67-79.
27. Musallam KM, Taher AT, Rachmilewitz EA. β-Thalassemia intermedia: A clinical perspective. Cold Spring Harb Perspect Med. 2012;2(7):a013482. doi. 10.1101/cshperspect.a013482.
28. Marsella M, Pepee A, Borgna-Pignatti C. Better survival and less cardiac morbidity in female patients with thalassemia major: A review of the literature. Ann N Y Acad Sci. 2010;1202:129-133.